Biostime to make equity-linked debut with $322m CB
Babycare products manufacturer Biostime International Holdings is in the market for HK$2.5bn ($322m) after launching a zero coupon convertible bond on January 14, its debut in equity-linked.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts